Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Weisman

Showing results (81-90 of 93) with videos related to

Pageof 10
Sort By:
Nature Communications|March 18, 2026
A blueprint for local and distal invasion programs in glioblastomaRony Chanoch-Myers, Toshiro Hara, Alissa C Greenwald, et al.
Critical Care Explorations|December 8, 2022
Validating a Proteomic Signature of Severe COVID-19Christopher V Cosgriff, Todd A Miano, Divij Mathew, et al.
Cancer Cell|April 5, 2024
Mutant IDH inhibitors induce lineage differentiation in IDH-mutant oligodendrogliomaAvishay Spitzer, Simon Gritsch, Masashi Nomura, et al.
Biorxiv : the Preprint Server for Biology|June 9, 2020
Immunologic perturbations in severe COVID-19/SARS-CoV-2 infectionLeticia Kuri-Cervantes, M Betina Pampena, Wenzhao Meng, et al.
Science Immunology|July 17, 2020
Comprehensive mapping of immune perturbations associated with severe COVID-19Leticia Kuri-Cervantes, M Betina Pampena, Wenzhao Meng, et al.
Biorxiv : the Preprint Server for Biology|May 11, 2021
Signaling through FcγRIIA and the C5a-C5aR pathway mediates platelet hyperactivation in COVID-19Sokratis A Apostolidis, Amrita Sarkar, Heather M Giannini, et al.
Frontiers in Immunology|March 21, 2022
Signaling Through FcγRIIA and the C5a-C5aR Pathway Mediate Platelet Hyperactivation in COVID-19Sokratis A Apostolidis, Amrita Sarkar, Heather M Giannini, et al.
Biorxiv : the Preprint Server for Biology|June 9, 2020
Deep immune profiling of COVID-19 patients reveals patient heterogeneity and distinct immunotypes with implications for therapeutic interventionsDivij Mathew, Josephine R Giles, Amy E Baxter, et al.
Science (New York, N.Y.)|July 17, 2020
Deep immune profiling of COVID-19 patients reveals distinct immunotypes with therapeutic implicationsDivij Mathew, Josephine R Giles, Amy E Baxter, et al.
Nature|July 26, 2019
Resolving medulloblastoma cellular architecture by single-cell genomicsVolker Hovestadt, Kyle S Smith, Laure Bihannic, et al.
Pageof 10

Showing results (81-90 of 93) with videos related to

Sort By:
Pageof 10
Nature Communications|March 18, 2026
A blueprint for local and distal invasion programs in glioblastomaRony Chanoch-Myers, Toshiro Hara, Alissa C Greenwald, et al.
Critical Care Explorations|December 8, 2022
Validating a Proteomic Signature of Severe COVID-19Christopher V Cosgriff, Todd A Miano, Divij Mathew, et al.
Cancer Cell|April 5, 2024
Mutant IDH inhibitors induce lineage differentiation in IDH-mutant oligodendrogliomaAvishay Spitzer, Simon Gritsch, Masashi Nomura, et al.
Biorxiv : the Preprint Server for Biology|June 9, 2020
Immunologic perturbations in severe COVID-19/SARS-CoV-2 infectionLeticia Kuri-Cervantes, M Betina Pampena, Wenzhao Meng, et al.
Science Immunology|July 17, 2020
Comprehensive mapping of immune perturbations associated with severe COVID-19Leticia Kuri-Cervantes, M Betina Pampena, Wenzhao Meng, et al.
Biorxiv : the Preprint Server for Biology|May 11, 2021
Signaling through FcγRIIA and the C5a-C5aR pathway mediates platelet hyperactivation in COVID-19Sokratis A Apostolidis, Amrita Sarkar, Heather M Giannini, et al.
Frontiers in Immunology|March 21, 2022
Signaling Through FcγRIIA and the C5a-C5aR Pathway Mediate Platelet Hyperactivation in COVID-19Sokratis A Apostolidis, Amrita Sarkar, Heather M Giannini, et al.
Biorxiv : the Preprint Server for Biology|June 9, 2020
Deep immune profiling of COVID-19 patients reveals patient heterogeneity and distinct immunotypes with implications for therapeutic interventionsDivij Mathew, Josephine R Giles, Amy E Baxter, et al.
Science (New York, N.Y.)|July 17, 2020
Deep immune profiling of COVID-19 patients reveals distinct immunotypes with therapeutic implicationsDivij Mathew, Josephine R Giles, Amy E Baxter, et al.
Nature|July 26, 2019
Resolving medulloblastoma cellular architecture by single-cell genomicsVolker Hovestadt, Kyle S Smith, Laure Bihannic, et al.
Pageof 10